PRETREATMENT FOLLICLE-STIMULATING HORMONE: A PROGNOSTIC SERUM MARKER OF SPERMATOGENESIS STATUS IN PATIENTS TREATED FOR GERM CELL CANCER
- 1 June 1998
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 159 (6) , 1942-1946
- https://doi.org/10.1016/s0022-5347(01)63203-8
Abstract
Purpose: We evaluate the use of pretreatment follicle-stimulating hormone (FSH) in patients with germ cell tumors as a prognostic serum marker of spermatogenesis after standard treatment. A...Keywords
This publication has 20 references indexed in Scilit:
- Immunoreactive plasma inhibin levels in men after polyvalent chemotherapy of germinal cell cancerActa Endocrinologica, 1992
- A Study of Post-Orchiectomy Surveillance in Stage I Testicular SeminomaJournal of Urology, 1989
- Testicular cancer in young norwegiansJournal of Surgical Oncology, 1988
- Leydig Cell Function in Infertile Men with Idiopathic Oligospermic InfertilityJournal of Clinical Endocrinology & Metabolism, 1988
- The Current Management of Testicular CancerBritish Journal of Urology, 1987
- Chronic gonadal toxicity in patients with testicular cancer after chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1986
- Control of FSH and LH SecretionPublished by Springer Nature ,1983
- Chemotherapy of disseminated testicular cancer a random prospective studyCancer, 1980
- The Relationship Between Germinal Cells and Serum FSH Levels in Males with Infertility1Journal of Clinical Endocrinology & Metabolism, 1974
- Relationship between Spermatogenesis and Serum Gonadotropin Levels in Azoospermia and OligospermiaJournal of Clinical Endocrinology & Metabolism, 1972